30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study-Reference-Cited by-同舟云学术

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

Published:2016-09 Issue:9 Volume:17 Page:1203-1216
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Wallington Michael,Saxon Emma B,Bomb Martine,Smittenaar Rebecca,Wickenden Matthew,McPhail Sean,Rashbass Jem,Chao David,Dewar John,Talbot Denis,Peake Michael,Perren Timothy,Wilson Charles,Dodwell David

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Chemotherapy and the war on cancer;Chabner;Nat Rev Cancer,2005

2. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies;Morgan;Clin Oncol,2004

3. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women;Fossati;J Clin Oncol,1998

4. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital Factors Influencing the Mobility of Patients for Systemic Therapies in Breast and Bowel Cancer in the Metastatic Setting: A National Population-based Evaluation;Clinical Oncology;2024-10

2. Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020;Blood Advances;2024-08-30

3. Understanding Nurses' Role in Systemic Anti-cancer Therapy Day Unit: A Qualitative Study;Seminars in Oncology Nursing;2024-08

4. Drug Delivery Systems for Natural Medicines in Cancer Therapy;Current Topics in Medicinal Chemistry;2024-07-31

5. Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer;Clinical Lung Cancer;2024-07